Markets mixed amid COVID-19 silver lining - Monday Review, February 22

Markets mixed amid COVID-19 silver lining - Monday Review, February 22

Investors cautious as significant economic and medical events took place

The US

Even though the number of COVID-19 infections continues to slow down, and vaccine rollouts gain pace, and a fiscal stimulus is expected to be approved, most markets closed in the red. USA30 rose 0.1%, while USA500 was down 0.77%. TECH100 dropped 2.46%.

Crude oil added 0.5% reaching $59.55 per barrel.

Gold rose 0.9% to $1,792.70 per ounce.

Asia and Australia

Markets were mostly up as the COVID-19 vaccines rollouts advance, and optimism grew for an economic recovery.

Japan225 jumped 0.26%.

HongKong45 inched up 0.05% as it received the first batch of Sinovac Biotech Ltd’s COVID-19 vaccine, and with the registration for priority groups set to open on Tuesday.

Down under, Australia200 edged down 0.14% after the country began its COVID-19 vaccine rollout and reported the third consecutive day with no new infection cases.

Europe

Stocks started the week cautiously, as investors focused on the vaccine rollouts and economic developments. Germany30 traded 1.3% lower. France40 and UK100 each dropped 1.1%.

Brent oil rose 0.6% to $62.53 a barrel.

EUR/USD traded 1.2102 after it lost 0.1%.

Sources: reuters.com, investing.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.